Review for "Impaired antigen-specific lymphocyte priming in mice after Toll-like receptor 4 activation via induction of monocytic myeloid-derived suppressor cells"

2019 ◽  
Vol 49 (4) ◽  
pp. 546-563 ◽  
Author(s):  
Hiroki Tsukamoto ◽  
Sao Kozakai ◽  
Yohei Kobayashi ◽  
Risako Takanashi ◽  
Takuya Aoyagi ◽  
...  

2016 ◽  
Vol 239 (4) ◽  
pp. 473-483 ◽  
Author(s):  
Jean-François Llitjos ◽  
Cédric Auffray ◽  
Fanny Alby-Laurent ◽  
Christophe Rousseau ◽  
Hamid Merdji ◽  
...  

Vaccines ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 522
Author(s):  
Ying Ying Kong ◽  
Kirsty Wilson ◽  
Vasso Apostolopoulos ◽  
Magdalena Plebanski

Dendritic cells (DCs) are commonly generated from bone marrow (BM) progenitor cells with granulocyte-macrophage colony-stimulating factor (GM-CSF) alone or in combination with interleukin 4 (IL-4). These cells are often harvested post day 5, when they acquire maturation markers and can stimulate T cells. Apart from DCs, myeloid derived suppressor cells (MDSCs) are also found within these cultures. However, little is known about the functional characteristics of DCs and MDSCs before day 5. Herein, using a murine model, it is shown that early DCs and MDSCs, even in cultures with GM-CSF alone, upregulate fully maturation and activation surface molecules in response to the toll-like receptor 4 (TLR4) ligand lipopolysaccharide (LPS) stimulation. Despite initially displaying lower marker expression levels, these cells efficiently induced T cell stimulation and cytokine production. Interestingly, Gr-1int MDSCs increased their T cell co-stimulatory activity upon TLR4 stimulation. Additionally, early DCs and MDSCs exhibited differential endocytic capacity for viral sized nanoparticles and bacterial sized microparticles. DCs internalized both particle sizes, whilst MDSCs only internalized the larger microparticles, with reduced endocytic activity over time in the culture. These findings have unveiled an important role for the rapid initiation of productive immunity by GM-CSF, with promising implications for future vaccine and DC immunotherapy developments.


Sign in / Sign up

Export Citation Format

Share Document